These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 24632542)

  • 1. Coronary artery calcification and cardiovascular disease in children with chronic kidney disease.
    Paoli S; Mitsnefes MM
    Curr Opin Pediatr; 2014 Apr; 26(2):193-7. PubMed ID: 24632542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FGF23 and Klotho in chronic kidney disease.
    Olauson H; Larsson TE
    Curr Opin Nephrol Hypertens; 2013 Jul; 22(4):397-404. PubMed ID: 23666415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into the FGF23-Klotho axis.
    Olauson H; Vervloet MG; Cozzolino M; Massy ZA; Ureña Torres P; Larsson TE
    Semin Nephrol; 2014 Nov; 34(6):586-97. PubMed ID: 25498378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGF23 protein expression in coronary arteries is associated with impaired kidney function.
    van Venrooij NA; Pereira RC; Tintut Y; Fishbein MC; Tumber N; Demer LL; Salusky IB; Wesseling-Perry K
    Nephrol Dial Transplant; 2014 Aug; 29(8):1525-32. PubMed ID: 24459137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Interaction of Soluble Klotho with FGF23 in the Pathobiology of Aortic Valve Lesions Induced by Chronic Kidney Disease.
    The E; Zhai Y; Yao Q; Ao L; Fullerton DA; Meng X
    Int J Biol Sci; 2024; 20(9):3412-3425. PubMed ID: 38993571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Klotho and endocrine fibroblast growth factors: markers of chronic kidney disease progression and cardiovascular complications?
    Kuro-O M
    Nephrol Dial Transplant; 2019 Jan; 34(1):15-21. PubMed ID: 29800324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency.
    Jimbo R; Kawakami-Mori F; Mu S; Hirohama D; Majtan B; Shimizu Y; Yatomi Y; Fukumoto S; Fujita T; Shimosawa T
    Kidney Int; 2014 May; 85(5):1103-11. PubMed ID: 24088960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Klotho/FGF23 Axis in CKD.
    Tsuchiya K; Nagano N; Nitta K
    Contrib Nephrol; 2015; 185():56-65. PubMed ID: 26023015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Klotho/FGF23 and Wnt Signaling as Important Players in the Comorbidities Associated with Chronic Kidney Disease.
    Muñoz-Castañeda JR; Rodelo-Haad C; Pendon-Ruiz de Mier MV; Martin-Malo A; Santamaria R; Rodriguez M
    Toxins (Basel); 2020 Mar; 12(3):. PubMed ID: 32188018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The intersection of mineralocorticoid receptor activation and the FGF23-Klotho cascade: a duopoly that promotes renal and cardiovascular injury.
    Epstein M; Freundlich M
    Nephrol Dial Transplant; 2022 Jan; 37(2):211-221. PubMed ID: 34459924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High fibroblast growth factor 23 is associated with coronary calcification in patients with high adiponectin: analysis from the KoreaN cohort study for Outcome in patients With Chronic Kidney Disease (KNOW-CKD) study.
    Hyun YY; Kim H; Oh YK; Oh KH; Ahn C; Sung SA; Choi KH; Kim SW; Lee KB
    Nephrol Dial Transplant; 2019 Jan; 34(1):123-129. PubMed ID: 29701806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The FGF23-Klotho axis and cardiac tissue Doppler imaging in pediatric chronic kidney disease-a prospective cohort study.
    Tranæus Lindblad Y; Olauson H; Vavilis G; Hammar U; Herthelius M; Axelsson J; Bárány P
    Pediatr Nephrol; 2018 Jan; 33(1):147-157. PubMed ID: 28795324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Klotho deficiency causes vascular calcification in chronic kidney disease.
    Hu MC; Shi M; Zhang J; Quiñones H; Griffith C; Kuro-o M; Moe OW
    J Am Soc Nephrol; 2011 Jan; 22(1):124-36. PubMed ID: 21115613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor 23 predicts coronary calcification and poor prognosis in patients with chronic kidney disease stages 3-5D.
    Zhang M; Yan J; Zhu M; Ni Z
    Ann Clin Lab Sci; 2015; 45(1):17-22. PubMed ID: 25696005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early chronic kidney disease-mineral bone disorder stimulates vascular calcification.
    Fang Y; Ginsberg C; Sugatani T; Monier-Faugere MC; Malluche H; Hruska KA
    Kidney Int; 2014 Jan; 85(1):142-50. PubMed ID: 23884339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does Fgf23-klotho activity influence vascular and soft tissue calcification through regulating mineral ion metabolism?
    Memon F; El-Abbadi M; Nakatani T; Taguchi T; Lanske B; Razzaque MS
    Kidney Int; 2008 Sep; 74(5):566-70. PubMed ID: 18528324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FGF23 and klotho at the intersection of kidney and cardiovascular disease.
    Edmonston D; Grabner A; Wolf M
    Nat Rev Cardiol; 2024 Jan; 21(1):11-24. PubMed ID: 37443358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular calcification in nondialyzed patients with chronic kidney disease.
    Qunibi WY
    Semin Dial; 2007; 20(2):134-8. PubMed ID: 17374087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vascular Calcification - Pathological Mechanism and Clinical Application - . Vascular calcification in chronic kidney disease-mineral and bone disorder (CKD-MBD)].
    Omata M; Fukagawa M; Kakuta T
    Clin Calcium; 2015 May; 25(5):645-53. PubMed ID: 25926567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular calcification in CKD-MBD: Roles for phosphate, FGF23, and Klotho.
    Yamada S; Giachelli CM
    Bone; 2017 Jul; 100():87-93. PubMed ID: 27847254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.